Dongjae Lee

Dongjae Lee

Auto-generated profile, based on publicly available information

Dongjae Lee

Division of Cardiology, Department of Internal Medicine Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea Seoul Republic of Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JBJaeho Byeon
Jaeho Byeon
ICIk Jun Choi
Ik Jun Choi
DLDongjae Lee
Dongjae Lee
YAYoungchul Ahn
Youngchul Ahn
MKMI-JEONG KIM
MI-JEONG KIM
DJDoo Soo Jeon
Doo Soo Jeon
Neutrophil gelatinase-associated lipocalin (NGAL) has been proposed as an early marker for estimating the risk of contrast-induced acute kidney injury (CI-AKI). However, the predictive value of baseline serum NGAL levels for CI-AKI remains unclear. Serum NGAL was measured before percutaneous coronary intervention in 633 patients with coronary artery disease. The primary clinical endpoints were a composite of major adverse cardiac and cerebrovascular events (MACCEs; cardiac death, myocardial infarction, stroke, and any revascularization). The mean follow-up duration was 29.4 months. Ninety-eight (15.5%) patients developed CI-AKI. Compared with patients without CI-AKI, baseline serum NGAL was higher in patients with CI-AKI (149.6 ± 88.8 ng/mL vs. 138.0 ± 98.6 ng/mL, p = 0.0279), although serum creatinine and estimated glomerular filtration rate were not different between groups. Patients in the highest tertile of baseline serum NGAL showed a significantly higher rate of MACCEs (10.5% vs. 3.8%, p = 0.02). Using the first tertile as a reference, the adjusted hazard ratios for MACCEs in patients in the second and third tertiles of NGAL were 2.151 (confidence interval (CI) 0.82 to 5.59, p = 0.116) and 2.725 (CI 1.05 to 7.05, p = 0.039), respectively. Baseline serum NGAL is a reliable marker for predicting CI-AKI, and high serum NGAL levels are associated with a higher incidence rate of long term MACCEs.

1 October 2020 in The American Journal of Cardiology
Verified
Journal Article
Closed access
ICIk Jun Choi
Ik Jun Choi
SLSungmin Lim
Sungmin Lim
DLDongjae Lee
Dongjae Lee
WLWon Jik Lee
Won Jik Lee
KLKwan Yong Lee
Kwan Yong Lee
DJDoo Soo Jeon
Doo Soo Jeon

8 November 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
YAYoungcheol Ahn
Youngcheol Ahn
DLDongjae Lee
Dongjae Lee
ECEun Ho Choo
Eun Ho Choo
ICIk Jun Choi
Ik Jun Choi
SLSungmin Lim
Sungmin Lim
KCKiyuk Chang
Kiyuk Chang
Background: Antithrombotic agents to treat patients with acute myocardial infarction can cause bleeding, which may reveal undiagnosed cancer. However, the relationship between bleeding and new cancer diagnosis and the prognostic impact is still unclear. Methods and Results: We analyzed the new cancer diagnosis, Bleeding Academic Research Consortium 2, 3, or 5 bleeding, and all‐cause death of 10 364 patients with acute myocardial infarction without a history of previous cancer in a multicenter acute myocardial infarction registry. During a median of 4.9 years, 1109 patients (10.7%) experienced Bleeding Academic Research Consortium 2, 3, or 5 bleeding, and 338 patients (3.3%) were newly diagnosed with cancer. Bleeding Academic Research Consortium 2, 3, or 5 bleeding was associated with an increased risk of new cancer diagnosis (subdistribution hazard ratio [sHR] 3.29 [95% CI, 2.50–4.32]). In particular, there were robust associations between gastrointestinal bleeding and new gastrointestinal cancer diagnosis (sHR, 19.96 [95% CI, 11.30–29.94]) and between genitourinary bleeding and new genitourinary cancer diagnosis (sHR, 28.95 [95% CI, 14.69–57.07]). The risk of all‐cause death was not lower in patients diagnosed with new gastrointestinal cancer after gastrointestinal bleeding (hazard ratio [HR], 4.05 [95% CI, 2.04–8.02]) and diagnosed with new genitourinary cancer after genitourinary bleeding (HR, 2.79 [95% CI, 0.81–9.56]) than in patients newly diagnosed with cancer without previous bleeding. Conclusions: Clinically significant bleeding, especially gastrointestinal and genitourinary bleeding, in patients with AMI was associated with an increased risk of new cancer diagnoses. However, the bleeding preceding new cancer detection was not associated with better survival. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02385682 and NCT02806102.

1 January 2020 in Cardiovascular Prevention and Pharmacotherapy
Verified
Journal Article
Open access
PDF file
DJDoo Soo Jeon
Doo Soo Jeon
MKMI-JEONG KIM
MI-JEONG KIM
WLWonjik Lee
Wonjik Lee
DLDongjae Lee
Dongjae Lee
ICIk Jun Choi
Ik Jun Choi
Jeon DS, et al. Cardiovasc Prev Pharmacother. 2020 Apr;2:e9. https://doi.org/10.36011/cpp.2020.2.e9